Evidence map›Paper›PMID 36583094›Full record

ArticleHemaSphere2023

Impact of Center-related Characteristics and Macroeconomic Factors on the Outcome of Adult Patients With Acute Lymphoblastic Leukemia Treated With Pediatric-inspired Protocols.

Pere Barba, Mireia Morgades, Pau Montesinos, Jose Gonzalez-Campos, Anna Torrent, Cristina Gil, Teresa Bernal, Mar Tormo, Santiago Mercadal, Sandra Novoa and 22 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in HemaSphere, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors.

Pere BarbaHematology Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Mireia MorgadesHematology Department, Institut Català d'Oncologia-Hospital Germans Trias i Pujol, Josep Carreras Research Institute, Badalona, Universitat Autònoma de Barcelona, Spain.
Pau MontesinosHematology Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain.
Jose Gonzalez-CamposHematology Department, Hospital Universitario Virgen del Rocío, Sevilla, Spain.
Anna TorrentHematology Department, Institut Català d'Oncologia-Hospital Germans Trias i Pujol, Josep Carreras Research Institute, Badalona, Universitat Autònoma de Barcelona, Spain.
Cristina GilHematology Department, Hospital General Universitario de Alicante, Spain.
Teresa BernalHematology Department, Hospital Universitario Central de Asturias, Oviedo, Spain.
Mar TormoHematology Department, Hospital Clínico Universitario de Valencia, Spain.
Santiago MercadalHematology Department, Institut Català d'Oncologia-Hospital Duran i Reynals, L'Hospitalet de Llobregat, Spain.
Sandra NovoaHematology Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Irene García-CadenasHematology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
M Paz Queipo de LlanoHematology Department, Hospital Universitario Virgen de la Victoria, Málaga, Spain.
Marta CerveraHematology Department, Institut Català d'Oncologia-Hospital Joan XXIII, Tarragona, Spain.
Rosa CollHematology Department, Institut Català d'Oncologia-Hospital Josep Trueta, Girona, Spain.
Arancha BermudezHematology Department, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
M Luz AmigoHematology Department, Hospital General Universitario Morales Meseguer, Murcia, Spain.
Silvia MonsalvoHematology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Jordi EsteveHematology Department, Hospital Clínic de Barcelona, IDIBAPS, Universitat de Barcelona, Spain.
Raimundo Garcia-BoyeroHematology Department, Hospital General Universitario de Castellón, Castellón de la Plana, Spain.
Andres NovoHematology Department, Hospital Universitari Son Espases, Palma de Mallorca, Spain.
Jesús Maria Hernandez RivasHematology Department, IBSAL, IBMCC, Centro de Investigación del Cáncer, CIBERONC, Universidad de Salamanca-CSIC, Hospital Universitario de Salamanca, Spain.
Antonia CladeraHematology Department, Hospital Universitari Son Llàtzer, Palma de Mallorca, Spain.
Pilar Martinez-SanchezHematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain.
Josefina SerranoHospital Universitario Reina Sofía, IMIBIC, Córdoba, Spain.
Maria Teresa ArtolaHematology Department, Hospital Universitario de Donostia, Spain.
Beatriz SoriaHematology Department, Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain.
Eugenia AbellaHematology Department, Hospital del Mar, Barcelona, Spain.
Ferran Vall-LloveraHematology Department, Hospital Universitari Mútua de Terrassa, Spain.
Juan BerguaHematology Department, Hospital San Pedro de Alcántara, Cáceres, Spain.
Pilar HerreraHematology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain.
Daniel BarriosHematology Department, Hospital Regional Universitario de Málaga, Spain.
Josep Maria RiberaHematology Department, Institut Català d'Oncologia-Hospital Germans Trias i Pujol, Josep Carreras Research Institute, Badalona, Universitat Autònoma de Barcelona, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID36583094
PMCPMC9794204

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.